Roche Alleges CareDx Breached Contract, Seeking $3.5M | GenomeWeb

NEW YORK (GenomeWeb) – CareDx disclosed in a regulatory filing on Thursday that Roche is seeking an estimated $3.5 million from the firm for allegedly breaching a licensing deal the companies brokered in 2004.

CareDx also said in its Form 10-Q filed with the US Securities and Exchange Commission that Illumina has made a $5 million investment in the firm.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.